Lifeboat Foundation

Shalev Hulio wants to explain himself.

Normally, silence and secrecy are inherent in the spy business. For nine full years, Hulio never talked publicly about his billion-dollar hacking company—even when his hacking tools were linked to scandal or he was accused of being complicit in human rights abuses around the world. Lately, though, he’s speaking up.

“People don’t understand how intelligence works,” Hulio tells me over a video call from Tel Aviv. “It’s not easy. It’s not pleasant. Intelligence is a shitty business full of ethical dilemmas.”

The MIT-Harvard Medical School Healthcare Innovation Bootcamp brings the rigorous, collaborative, action-learning experience of our in-person Healthcare Innovation Bootcamps online. Over 10 weeks, you’ll have the opportunity to work with a global team of innovators selected by MIT Bootcamps to build the foundations of a new healthcare venture. You will learn principles… See More.

The MIT — Harvard Medical School Healthcare Innovation Bootcamp will be different than most online courses you can take. A combination of live teaching sessions and workshops (which are recorded for your flexibility), office hours, building the foundations of a venture with your global team, and receiving regular team-based coaching, the Bootcamp is a hands-on, immersive, and rigorous learning experience. In 10 weeks, you’ll learn to identify an innovation opportunity, develop a superior solution, and select a business model for the venture you build with your global team. Expect to spend 10–15 hours per week on live sessions, individual, and team work.

SpaceX, the Elon Musk-led company that recently became the first business in history to send astronauts into Earth’s orbit, is parlaying its successes into big money.

In a bitter paradox, antibiotics fuelled the growth of the twentieth century’s most profitable pharmaceutical companies, and are one of society’s most desperately needed classes of drug. Yet the market for them is broken. For almost two decades, the large corporations that once dominated antibiotic discovery have been fleeing the business, saying that the prices they can charge for these life-saving medicines are too low to support the cost of developing them. Most of the companies now working on antibiotics are small biotechnology firms, many of them running on credit, and many are failing.

Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question?

Primer Labs features examples that A.I. systems capable of natural language processing are poised to have a big impact on business.

Life-sciences companies have yet to realize the full potential of digital and analytics. Pioneers are finding success by focusing on entire parts of the business system rather than use case projects.

Humans will soon have new bodies that forever blur the line between the natural and synthetic worlds, says bionics designer Hugh Herr. In an unforgettable talk, he details “NeuroEmbodied Design,” a methodology for creating cyborg function that he’s developing at the MIT Media Lab, and shows us a future where we’ve augmented our bodies in a way that will redefine human potential — and, maybe, turn us into superheroes. “During the twilight years of this century, I believe humans will be unrecognizable in morphology and dynamics from what we are today,” Herr says. “Humanity will take flight and soar.”

Check out more TED Talks: http://www.ted.com

Continue reading “How we’ll become cyborgs and extend human potential | Hugh Herr” »

OpenAI’s new language generator #GPT-3 is shockingly good—and completely mindless: https://bit.ly/3kphfsX

By Will Douglas Heavenarchive page from MIT Technolgy Review

#AI #MachineLearning #NeuralNetworks #DeepLearning

Continue reading “OpenAI’s new language generator GPT-3 is shockingly good—and completely mindless” »

Quantum computing requires meticulously prepared hardware and big budgets, but cloud-based solutions could make the technology available to broader business audiences Several tech giants are racing to achieve “quantum supremacy”, but reliability and consistency in quantum output is no simple trick Covid-19 has prompted some researchers to look at how quantum computing could mitigate future pandemics with scientific precision and speed Quantum computing (QC) has been theorized for decades and has evolved rapidly over the last few years. An escalation in spend and development has seen powerhouses IBM, Microsoft, and Google race for ‘quantum supremacy’ — whereby quantum reliably and consistently outperforms existing computers. But do quantum computers remain a sort of elitist vision of the future or are we on course for more financially and infrastructurally viable applications across industries?

Getting to grips with qubits How much do you know? Ordinary computers (even supercomputers) deploy bits, and these bits comprise of traditional binary code. Computer processes – like code – are made up of countless combinations of 0’s and 1’s. Quantum computers, however, are broken down into qubits. Qubits are capable of ‘superpositions’: effectively adopting both 1 and 0 simultaneously, or any space on the spectrum between these two formerly binary points. The key to a powerful, robust, and reliable quantum computer is more qubits. Every qubit added exponentially increases the processing capacity of the machine.

Qubits and the impact of the superposition give quantum computers the ability to process large datasets within seconds, doing what it would take humans decades to do. They can decode and deconstruct, hypothesize and validate, tackling problems of absurd complexity and dizzying magnitude — and can do so across many different industries.

Continue reading “The quantum state of play — cloud-based QCaaS and Covid-19” »